Fidelity Wise Origin Bitcoin Fund amends trust agreement to allow in-kind share transactions
LONDON - Shareholders of Induction Healthcare Group PLC have voted in favor of a cash acquisition by VitalHub UK Limited, a subsidiary of VitalHub Corp. The approval, which took place at a court meeting and a general meeting today, moves the acquisition process forward under a court-sanctioned scheme of arrangement.
At the court meeting, 91.63% of the votes cast by Scheme Shareholders were in favor of the acquisition, with 64.83% of the issued share capital entitled to vote on the scheme represented. At the subsequent general meeting, the resolution to implement the scheme received 92.49% support from Induction Shareholders, with 65.54% of the issued share capital voting.
The acquisition, initially announced on April 10, 2025, will result in VitalHub acquiring the entire issued and to be issued ordinary share capital of Induction. The conditions for the acquisition, detailed in a scheme document published on April 17, 2025, have now been met with the shareholders’ approval.
The transaction is still subject to further conditions, including approval from the Secretary of State in connection with a mandatory notification under the NSIA and the sanctioning of the scheme at a court hearing. If these conditions are met or waived where applicable, Induction expects the scheme to become effective before the end of the third quarter of 2025.
The acquisition is part of a broader consolidation trend within the healthcare technology sector, as companies seek to expand their offerings and market reach. Induction Healthcare’s decision to merge with VitalHub UK Limited reflects this ongoing industry movement, aiming to create a more comprehensive healthcare technology entity.
Details of the votes and the next steps for the acquisition have been disseminated through a Regulatory Information Service and are also available on Induction Healthcare’s website. The information in this article is based on a press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.